These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 3010317)

  • 1. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
    Campbell KP; Sharp A; Strom M; Kahl SD
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antibody to dihydropyridine calcium entry blockers. A comparison with the calcium channel receptor in skeletal muscle.
    Thayer SA; Pham DH; Schultz CM; Minaskanian G; Fairhurst AS
    Biochem Pharmacol; 1986 Dec; 35(24):4479-85. PubMed ID: 3024651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity purification of antibodies specific for 1,4-dihydropyridine Ca2+ channel blockers.
    Sharp AH; Campbell KP
    Circ Res; 1987 Oct; 61(4 Pt 2):I37-45. PubMed ID: 3308157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site.
    Zobrist RH; Giacomini KM; Nelson WL; Giacomini JC
    J Mol Cell Cardiol; 1986 Sep; 18(9):963-74. PubMed ID: 3783730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of receptor sites for [3H]nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling.
    Renaud JF; Kazazoglou T; Schmid A; Romey G; Lazdunski M
    Eur J Biochem; 1984 Mar; 139(3):673-81. PubMed ID: 6321185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
    Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
    Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT; Tremble P
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
    Maan AC; Hosey MM
    Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
    Homaidan FR; Donowitz M; Weiland GA; Sharp GW
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes.
    Gopalakrishnan V; Triggle CR
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1249-52. PubMed ID: 6498637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P
    J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors.
    Thayer SA; Welcome M; Chhabra A; Fairhurst AS
    Biochem Pharmacol; 1985 Jan; 34(2):175-80. PubMed ID: 2981533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine increases the affinity of dihydropyridine calcium channel antagonist binding in rat brain.
    Bolger GT; Rafferty MF; Skolnick P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):227-34. PubMed ID: 2932650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]nitrendipine receptors in skeletal muscle.
    Fosset M; Jaimovich E; Delpont E; Lazdunski M
    J Biol Chem; 1983 May; 258(10):6086-92. PubMed ID: 6304026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
    Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
    J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.